Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women
- PMID: 21800289
- DOI: 10.1002/cncr.26405
Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women
Abstract
Background: Breast tumors from African American women have less favorable pathological characteristics and higher mortality rates than those of Caucasian women. Although socioeconomic status may influence prognosis, biological factors are also likely to contribute to tumor behavior.
Methods: Patients with invasive breast cancer were matched by age, grade, and estrogen receptor status; patients with benign disease were matched by age and diagnosis type. RNA from laser microdissected tumors and whole-sectioned nonmalignant breast tissues was hybridized to HG U133A 2.0 microarrays. Data were analyzed using Partek Genomics Suite using a cutoff of P < .001, >1.5-fold change, and results were validated by quantitative real-time polymerase chain reaction.
Results: Clinicopathological factors did not differ significantly between groups for age at diagnosis, tumor size or stage, lymph node or human epidermal growth receptor 2 status, intrinsic subtype, or mortality. Two-way analysis of the tumor specimens revealed 25 probes representing 23 genes differentially expressed between populations; hierarchical clustering classified 24 of 26 African American women and 25 of 26 Caucasian women correctly. In the nonmalignant specimens, 15 probes representing 13 genes were differentially expressed, including 5 genes that also differed in the tumor specimens; these genes were able to correctly classify nonmalignant breast specimens from 20 of 22 of African American women and all of the Caucasian women.
Conclusions: Despite matching of tumors by pathological characteristics, molecular profiles differed between African American women and Caucasian women in both invasive tumors and benign breast tissues. These differentially expressed genes, including CRYBB2, PSPHL, and SOS1, are involved in cellular growth and differentiation, invasion, metastasis, and immune response and thus may contribute to the poor outcome in African American women.
Copyright © 2011 American Cancer Society.
Similar articles
-
Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.BMC Res Notes. 2012 May 22;5:248. doi: 10.1186/1756-0500-5-248. BMC Res Notes. 2012. PMID: 22616718 Free PMC article.
-
Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women.Cancer. 2003 Sep 1;98(5):908-17. doi: 10.1002/cncr.11558. Cancer. 2003. PMID: 12942556
-
Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.BMC Cancer. 2014 Feb 4;14:62. doi: 10.1186/1471-2407-14-62. BMC Cancer. 2014. PMID: 24495414 Free PMC article.
-
Racial differences in genetic factors associated with breast cancer.Cancer Metastasis Rev. 2003 Mar;22(1):47-53. doi: 10.1023/a:1022259901319. Cancer Metastasis Rev. 2003. PMID: 12716036 Review.
-
The therapeutic value of natural agents to treat miRNA targeted breast cancer in African-American and Caucasian-American women.Curr Drug Targets. 2012 Dec;13(14):1917-25. doi: 10.2174/138945012804545461. Curr Drug Targets. 2012. PMID: 23140300 Review.
Cited by
-
Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer.Womens Health Rep (New Rochelle). 2020 Sep 24;1(1):383-392. doi: 10.1089/whr.2020.0037. eCollection 2020. Womens Health Rep (New Rochelle). 2020. PMID: 33786503 Free PMC article. Review.
-
Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzyme.J Biol Chem. 2015 May 15;290(20):12879-98. doi: 10.1074/jbc.M114.634493. Epub 2015 Mar 30. J Biol Chem. 2015. PMID: 25825487 Free PMC article.
-
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.Breast Cancer Res Treat. 2017 Jun;163(2):321-330. doi: 10.1007/s10549-017-4166-z. Epub 2017 Mar 1. Breast Cancer Res Treat. 2017. PMID: 28251385 Free PMC article.
-
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines.Int J Breast Cancer. 2018 Sep 30;2018:2063540. doi: 10.1155/2018/2063540. eCollection 2018. Int J Breast Cancer. 2018. PMID: 30363973 Free PMC article.
-
LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.Breast Cancer (Dove Med Press). 2018 Dec 20;11:1-12. doi: 10.2147/BCTT.S185960. eCollection 2019. Breast Cancer (Dove Med Press). 2018. PMID: 30588086 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
